by Alex Brown | Oct 20, 2023 | News
Meet with Vici at AAPS 2023 PharmSci 360 Are you looking for a high quality, US-based, full service R&D focused CDMO to accelerate your drug development program? Meet with our CEO, Dr Anish Dhanarajan and Senior Director of R&D, Dr Suneel Rastogi at AAPS next...
by Alex Brown | Aug 29, 2023 | News
Vici will be exhibiting at the 22nd Annual Contract Pharma Conference September 21-22, 2023 Hyatt Regency, New Brunswick NJ. As a proud Gold Level Sponsor of the event, Vici invites you to Table 101 to understand your pharmaceutical R&D needs and discuss how we...
by Alex Brown | Jul 14, 2023 | News
Through strong partnerships with our sister manufacturing company, Vici is now able to provide Phase 3 clinical manufacturing services to support NDA programs. With this offering, Vici is able to offer a full range of integrated CDMO services starting from early phase...
by Alex Brown | Jul 12, 2023 | News
Dr. Rastogi has over 24 years of extensive experience in the development of a variety of conventional and complex dosage forms including oral dosage forms, injectables, long acting, amorphous solid dispersions, ophthalmic, topical, nano particulates, peptides, nasal...
by Alex Brown | Apr 19, 2023 | News
Vici Health, a world class pharmaceutical product development company, announced that it will be exhibiting at the CPHI North America Conference in Philadelphia, Pennsylvania April 25-27, 2023. Based in Maryland, USA, Vici provides CDMO services that include API...
by Alex Brown | Nov 15, 2022 | News
ELKRIDGE, MD. (PRWEB) DECEMBER 31, 2019 Vici Health Sciences announces it is breaking ground in expanding its pharmaceutical product development lab in Maryland. Emphasis will be in expanding capabilities in both oral and parenteral dosage forms. With the increased...
